Baird Financial Group, Inc. Procept Bio Robotics Corp Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$56.03 - $88.57 $889,756 - $1.41 Million	15,880 Added 29.28%	70,117 $4.09 Million
Q4 2024 Feb 14, 2025	BUY	$67.27 - $99.45 $1.03 Million - $1.52 Million	15,327 Added 39.39%	54,237 $4.37 Million
Q3 2024 Nov 13, 2024	SELL	$56.31 - $84.99 $371,589 - $560,849	-6,599 Reduced 14.5%	38,910 $3.12 Million
Q2 2024 Aug 13, 2024	BUY	$45.73 - $69.19 $2.08 Million - $3.15 Million	45,509 New	45,509 $2.78 Million

272

49.1M

274K

376K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.32B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.